Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 462Terminated 203Active not recruiting 37Unknown 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 12Thoracic 9Gynecologic 9Gastrointestinal 9Lymphoid 6Other hematologic neoplasm 5Genitourinary 4Other 3Myeloid 2Sarcoma 1Plasma cell 1NET 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1

Conditions

Primary Myelofibrosis 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Megakaryoblastic, Acute 1

Interventions

treosulfan 1fludarabine phosphate 1Whole-Body Irradiation 1Peripheral Blood Stem Cell Transplantation 1MLN 8237 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Has results × Myeloid × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

NCT02530619 2021-05-26

Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia

Northwestern University

Phase NA Unknown
26 enrolled 10 charts
MyeloidOther hematologic neoplasm

Leukemia, Megakaryoblastic, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡